An Investigative Study to characterize gene expression patterns in myeloid cells that are triggered during acute asthma exacerbations, and to identify associated genes/gene networks that are Omalizumab sensitive.
Phase of Trial: Phase IV
Latest Information Update: 18 Sep 2014
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Pharmacodynamics; Pharmacogenomic
- 30 Aug 2012 New trial record